Brief: Baudax Bio Announces Pricing Of 3.5 Million Shares Of Its Common Stock At A Price Of $1.15 Per Share
April 26 (Reuters) - Baudax Bio Inc BXRX.O :
* BAUDAX BIO ANNOUNCES PRICING OF $4 MILLION PUBLIC OFFERING
* BAUDAX BIO INC BXRX.O - ANNOUNCED PRICING OF ITS PUBLIC
OFFERING OF AN AGGREGATE OF 3.5 MLN SHARES OF ITS COMMON STOCK
AT AN EXERCISE PRICE OF $1.15 PER SHARE
Source text for Eikon: ID:nGNX4Fts1X
Further company coverage: BXRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer